UK drug price rises 'necessary', says Patrick Vallance
NeutralFinancial Markets

Patrick Vallance, the UK's chief scientific adviser, stated that recent drug price increases are necessary. This comes in light of several pharmaceutical companies pausing or canceling projects in the UK, raising concerns about the future of drug development in the country. Vallance's remarks highlight the delicate balance between ensuring affordable medications and maintaining a viable environment for pharmaceutical innovation.
— Curated by the World Pulse Now AI Editorial System